Schering-Plough seems pretty fired up about its joint venture with Merck to create a single pill combining Schering's allergy medicine Claritin with Merck's asthma drug Singulair. 先灵葆雅似乎决意通过其与默克合作开发的一种复合了先灵的抗过敏药克敏能和默克的抗哮喘药顺尔宁的药丸来打一场翻身仗。
Maybe that's because Claritin, known generically as loratadine, lost patent protection a while back and had sales of less than$ 800 million last year, down from the year before. 可能是因为划属于氯雷他定的克敏能在前阵子失去了专利保护,去年的销售额低于8亿美元,比前年要低。